Ortho Regenerative Technologies (CSE:ORTH) CEO Claude LeDuc sat down with Steve Darling from Proactive at the 12th annual LD Micro Conference in Bel Air. The Montreal-based company specializes in developing therapeutic soft tissue repair technologies to improve the success rate of orthopaedic and sports medicine surgeries.
Ortho Regenerative Technologies looking at a new way to treat rotator cup injuries
Quick facts: Ortho Regenerative Technologies
Price: 0.58 CAD
Market Cap: $14.36 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE